Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Growth and Trends: Key Insights into Market Opportunities for 2025-2034
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The escalating incidences of eye diseases are anticipated to boost the development of the minimally invasive glaucoma surgery (MIGS) devices market in the future. Eye disorders consist of an array of conditions undermining vision and eye health. The surge in eye disorders can be attributed to modifying lifestyles, environmental factors, and aging demographics. Minimally invasive glaucoma surgery (MIGS) tools are state-of-the-art devices employed in the treatment of an assortment of eye disorders, their main objective being the reduction of intraocular pressure (IOP) to halt or manage glaucoma. For instance, projections by the National Eye Institute, a government agency based in the US, suggest that approximately 2.2 million Americans will suffer complete or partial blindness by 2030. Consequently, the rising frequency of eye disorders propels the market for minimally invasive glaucoma surgery (MIGS) devices.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
#What is the Anticipated CAGR of theMinimally Invasive Glaucoma Surgery (MIGS) Devices Market, and What Factors Will Drive It?
In recent times, there has been significant growth in the market size of minimally invasive glaucoma surgery (MIGS) devices. A growth projection from $0.7 billion in 2024 to $0.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 28.3%, is envisaged. This phenomenal rise during the historic period can be linked to enhanced alertness concerning blindness prevention, escalation in healthcare infrastructure investments, augmented patient cognizance about advanced vision correction techniques, as well as government initiatives aimed at promoting these treatments.
The market size of minimally invasive glaucoma surgery (MIGS) devices is predicted to grow significantly in the coming years. It is estimated that the market will reach $2.42 billion in 2029, with a compound annual growth rate (CAGR) of 28.1%. The growth during the projected period is attributed to an increased occurrence of eye illnesses such as glaucoma, a growing elderly population, enhancements in healthcare infrastructure, and a rising demand for safer and more effective treatments. Key trends observed during the forecast period include the use of MIGS devices, technological advancements, the development of innovative minimally invasive glaucoma surgery devices, advanced implantable devices’ emergence, and improvements in ophthalmic technology.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15863
What Are the Key Market Innovations in theMinimally Invasive Glaucoma Surgery (MIGS) Devices Market Over the Coming Years?
Principal enterprises in the minimally invasive glaucoma surgery (MIGS) devices sector are keen on developing unique products like stent injectable systems, aiming to fill the gaps in glaucoma management and better patient outcomes. A stent injectable system is a MIGS device that by using an injection-like process, implants a tiny stent into the body. This process often involves a special delivery mechanism used frequently in minimally invasive surgeries for treating conditions like blocked or constricted blood vessels. For instance, in August 2022, Glaukos Corporation, an ophthalmic medical tech firm based in the USA, received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its iStent Infinite Trabecular Micro-Bypass System. This iStent Infinite is an innovative three-stent injectable system, designed to provide round-the-clock intraocular pressure (IOP) regulation to patients with primary open-angle glaucoma (POAG) that is not managed by previous medication or surgical intervention.
Who Are the Top Companies Driving Innovation and Growth in theMinimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are AbbVie Inc., Novartis AG, Alcon Inc., Bausch Health Companies Inc., Bausch & Lomb Incorporated Inc., Carl Zeiss Meditec AG, Santen Pharmaceutical Co. Ltd., Johnson & Johnson Vision Care Inc., Lumenis Ltd., Staar Surgical Company, Glaukos Corporation, Sight Sciences Inc., Ocular Therapeutix Inc., Iridex Corporation, Ellex Medical Lasers Ltd., New World Medical Inc., MicroSurgical Technology Inc., Nova Eye Medical Limited, Asico LLC, Ziemer Ophthalmic Systems AG, Transcend Medical, iSTAR Medical SA, Ivantis Group Inc., Allergan, InnFocus Inc.
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market and Drive Its Revenue Growth?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15863&type=smp
Which Regions Are Emerging as Leaders in the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025, By The Business Research Company:
Minimally Invasive Surgery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report
Non-Invasive Ventilators Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-invasive-ventilators-global-market-report
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
